{
    "organizations": [],
    "uuid": "c494e6ae7363035664fac68cfa69a66d4dccdde5",
    "author": "",
    "url": "https://www.reuters.com/article/brief-acerus-reports-q4-loss-per-share-0/brief-acerus-reports-q4-loss-per-share-0-01-idUSASC09T40",
    "ord_in_thread": 0,
    "title": "BRIEF-Acerus Reports Q4 Loss Per Share $0.01",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 21, 2018 / 10:05 AM / Updated 13 minutes ago BRIEF-Acerus Reports Q4 Loss Per Share $0.01 Reuters Staff March 21 (Reuters) - Acerus Pharmaceuticals Corporation : * ACERUS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS * Q4 LOSS PER SHARE $0.01 * TOTAL Q4 REVENUES INCREASED TO $2.1 MILLION FROM $1.8 MILLION IN SAME PRIOR YEAR PERIOD Source text for Eikon: Further company coverage:",
    "published": "2018-03-21T12:04:00.000+02:00",
    "crawled": "2018-03-21T12:22:46.002+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "updated",
        "minute",
        "ago",
        "report",
        "q4",
        "loss",
        "per",
        "share",
        "reuters",
        "staff",
        "march",
        "reuters",
        "acerus",
        "pharmaceutical",
        "corporation",
        "acerus",
        "report",
        "fourth",
        "quarter",
        "full",
        "year",
        "financial",
        "result",
        "q4",
        "loss",
        "per",
        "share",
        "total",
        "q4",
        "revenue",
        "increased",
        "million",
        "million",
        "prior",
        "year",
        "period",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}